Over the past decade, human papillomavirus (HPV) vaccinations have prevented thousands of cervical cancer cases worldwide.
Beginning in July 2025, the enhanced 9-valent HPV vaccine will become more available in the Region of the Americas.
The Pan American Health Organization (PAHO) Revolving Fund announced on February 7, 2025, that the general availability of the 9-valent HPV vaccine will be easier and more affordable for Latin American countries.
Read More
